Bringing the fundamentals into focus…
Back to Takeda Pharmaceutical Company Limited
How Takeda Pharmaceutical Company Limited stacks up
TAK · against 54 other Healthcare companies of similar size
Profitability
37/ 100
Near the bottom of its peers.
Ranked #51 of 55 · scores higher than 7% of peers
Bars: peers in each 10-point band of the profitability score1 peers with a profitability score of 30–39, including TAK · Click a bar to see the companies
Why profitability scores 37?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 67% of peers. Operating margin: 0.1% vs peer median 7.1%
- a lower return on invested capital: weaker than 64% of peers. Return on invested capital: 0.0% vs peer median 4.7%
- a lower return on assets: weaker than 62% of peers. Return on assets: -1.0% vs peer median 1.7%
Metric by metric
Position: dot = TAK, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TAK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 53 reported | 0.0% | 11.4% | 8% | 33% | |
| Operating marginHigher is better · 53 reported | 0.1% | 19.8% | 6% | 33% | |
| Return on assetsHigher is better · 54 reported | -1.0% | 5.8% | 8% | 33% | |
| Return on equityHigher is better · 49 reported | -2.3% | 13.4% | 10% | Context only | |
| Gross marginHigher is better · 55 reported | 64.5% | 59.8% | 57% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around TAK| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 11.26T JPY (≈$76.6B) | 99 | 72 | |
| 1 | 52.9B USD | 99 | 57 | |
| 3 | 8.24T JPY (≈$56.0B) | 98 | 75 | |
| 4 | 34.0B USD | 97 | 49 | |
| 5 | 534.1B HKD (≈$68.4B) | 96 | 75 | |
| 47 | 89.7B USD | 52 | 50 | |
| 48 | 50.2B USD | 50 | 49 | |
| 49 | 116.9B USD | 44 | 47 | |
| 50 | 45.2B USD | 43 | 46 | |
| 51 | 66.3B USD | 37 | 30 | |
| 52 | 33.3B USD | 27 | 24 | |
| 53 | 56.0B USD | 26 | 39 | |
| 54 | 91.2B USD | 14 | 18 | |
| 54 | 41.6B USD | 14 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score